ロード中...
Lower adalimumab trough levels are associated with higher bowel wall thickness in Crohn's disease
BACKGROUND: In Crohn's disease, higher adalimumab trough levels and negative anti-adalimumab-antibodies associate with better clinical and endoscopic outcomes. Intestinal ultrasound has become a relevant non-invasive method to monitor treatment. However, data on the association between adalimum...
保存先:
| 出版年: | United European Gastroenterol J |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7079273/ https://ncbi.nlm.nih.gov/pubmed/32213067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619878974 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|